Abstract
Development of preterm infant lungs is frequently impaired resulting in bronchopulmoary dysplasia (BPD). BPD results from interruption of physiologic anabolic intrauterine conditions, the inflammatory basis and therapeutic consequences of premature delivery, including increased oxygen supply for air breathing. The latter requires surfactant, produced by alveolar type II (AT II) cells to lower surface tension at the pulmonary air:liquid interface. Its main components are specific phosphatidylcholine (PC) species including dipalmitoyl-PC, anionic phospholipids and surfactant proteins. Local antioxidative enzymes are essential to cope with the pro-inflammatory side effects of normal alveolar oxygen pressures. However, respiratory insufficiency frequently requires increased oxygen supply. To cope with the injurious effects of hyperoxia to epithelia, recombinant human keratinocyte growth factor (rhKGF) was proposed as a surfactant stimulating, non-catabolic and epithelial-protective therapeutic. The aim of the present study was to examine the qualification of rhKGF to improve expression parameters of lung maturity in newborn rats under hyperoxic conditions (85 % O2 for 7 days). In response to rhKGF proliferating cell nuclear antigen mRNA, as a feature of stimulated proliferation, was elevated. Similarly, the expressions of ATP-binding cassette protein A3 gene, a differentiation marker of AT II cells and of peroxiredoxin 6, thioredoxin and thioredoxin reductase, three genes involved in oxygen radical protection were increased. Furthermore, mRNA levels of acyl-coA:lysophosphatidylcholine acyltransferase 1, catalyzing dipalmitoyl-PC synthesis by acyl remodeling, and adipose triglyceride lipase, considered as responsible for fatty acid supply for surfactant PC synthesis, were elevated. These results, together with a considerable body of other confirmative evidence, suggest that rhKGF should be developed into a therapeutic option to treat preterm infants at risk for impaired lung development.
Similar content being viewed by others
References
Anhoj J, Bisgaard AM, Bisgaard H (2002) Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma. Pediatrics 109:E40
Atabai K, Ishigaki M, Geiser T, Ueki I, Matthay MA, Ware LB (2002) Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am J Physiol Lung Cell Mol Physiol 283:L163–L169
Bassler D, Halliday HL, Plavka R, Hallman M, Shinwell ES, Jarreau PH, Carnielli V, van den Anker J, Schwab M, Poets CF (2011) The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants. Neonatology 97:52–55
Batenburg JJ (1992) Surfactant phospholipids: synthesis and storage. Am J Physiol 262:L367–L385
Bellusci S, Grindley J, Emoto H, Itoh N, Hogan BL (1997) Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 124:4867–4878
Bernhard W, Schmiedl A, Koster G, Orgeig S, Acevedo C, Poets CF, Postle AD (2007) Developmental changes in rat surfactant lipidomics in the context of species variability. Pediatr Pulmonol 42:794–804
Besnard V, Matsuzaki Y, Clark J, Xu Y, Wert SE, Ikegami M, Stahlman MT, Weaver TE, Hunt AN, Postle AD, Whitsett JA (2010) Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice. Am J Physiol Lung Cell Mol Physiol 298:L646–L659
Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA (2001) Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 32:76–91
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brasch F, Schimanski S, Muhlfeld C, Barlage S, Langmann T, Aslanidis C, Boettcher A, Dada A, Schroten H, Mildenberger E, Prueter E, Ballmann M, Ochs M, Johnen G, Griese M, Schmitz G (2006) Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 174:571–580
Cardoso WV, Lu J (2006) Regulation of early lung morphogenesis: questions, facts and controversies. Development 133:1611–1624
Carvalho CR, de Paula Pinto Schettino G, Maranhao B, Bethlem EP (1998) Hyperoxia and lung disease. Curr Opin Pulm Med 4:300–304
Castoldi G, di Gioia CR, Bombardi C, Catalucci D, Corradi B, Gualazzi MG, Leopizzi M, Mancini M, Zerbini G, Condorelli G, Stella A (2011) MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 227:850–856
Chelly N, Mouhieddine-Gueddiche OB, Barlier-Mur AM, Chailley-Heu B, Bourbon JR (1999) Keratinocyte growth factor enhances maturation of fetal rat lung type II cells. Am J Respir Cell Mol Biol 20:423–432
Chelly N, Henrion A, Pinteur C, Chailley-Heu B, Bourbon JR (2001) Role of keratinocyte growth factor in the control of surfactant synthesis by fetal lung mesenchyme. Endocrinology 142:1814–1819
Chen X, Hyatt BA, Mucenski ML, Mason RJ, Shannon JM (2006) Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc Natl Acad Sci USA 103:11724–11729
Crosby LM, Luellen C, Zhang Z, Tague LL, Sinclair SE, Waters CM (2011) Balance of life and death in alveolar epithelial type II cells: proliferation, apoptosis, and the effects of cyclic stretch on wound healing. Am J Physiol Lung Cell Mol Physiol 301:L536–L546
Danilenko DM (1999) Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol 27:64–71
Das KC, Guo XL, White CW (1999) Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am J Physiol 276:L530–L539
Dobbs LG, Gonzalez R, Williams MC (1986) An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis 134:141–145
Dombrowsky H, Tschernig T, Vieten G, Rau GA, Ohler F, Acevedo C, Behrens C, Poets CF, von der Hardt H, Bernhard W (2006) Molecular and functional changes of pulmonary surfactant in response to hyperoxia. Pediatr Pulmonol 41:1025–1039
Emura M, Riebe M, Ochiai A, Aufderheide M, Germann P, Mohr U (1990) New functional cell-culture approach to pulmonary carcinogenesis and toxicology. J Cancer Res Clin Oncol 116:557–562
Esper AM, Moss M, Martin GS (2009) The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 13:R18
Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139–149
Fehrenbach H, Kasper M, Koslowski R, Pan T, Schuh D, Muller M, Mason RJ (2000) Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat. Histochem Cell Biol 114:49–61
Fisher AB (2011) Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A activities. Antioxid Redox Signal 15:831–844
Fisher AB, Dodia C (2001) Lysosomal-type PLA2 and turnover of alveolar DPPC. Am J Physiol Lung Cell Mol Physiol 280:L748–L754
Fisher AB, Dodia C, Feinstein SI, Ho YS (2005) Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. J Lipid Res 46:1248–1256
Fisher AB, Dodia C, Yu K, Manevich Y, Feinstein SI (2006) Lung phospholipid metabolism in transgenic mice overexpressing peroxiredoxin 6. Biochim Biophys Acta 1761:785–792
Fitzgerald ML, Xavier R, Haley KJ, Welti R, Goss JL, Brown CE, Zhuang DZ, Bell SA, Lu N, McKee M, Seed B, Freeman MW (2007) ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res 48:621–632
Franco-Montoya ML, Bourbon JR, Durrmeyer X, Lorotte S, Jarreau PH, Delacourt C (2009) Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 297:L965–L976
Frank S, Munz B, Werner S (1997) The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene 14:915–921
French NP, Hagan R, Evans SF, Godfrey M, Newnham JP (1999) Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180:114–121
Galiacy S, Planus E, Lepetit H, Fereol S, Laurent V, Ware L, Isabey D, Matthay M, Harf A, d‘Ortho MP (2003) Keratinocyte growth factor promotes cell motility during alveolar epithelial repair in vitro. Exp Cell Res 283:215–229
Gallagher BM, Phelan SA (2007) Investigating transcriptional regulation of Prdx6 in mouse liver cells. Free Radic Biol Med 42:1270–1277
Gesche J, Fehrenbach H, Koslowski R, Ohler FM, Pynn CJ, Griese M, Poets CF, Bernhard W (2011) rhKGF stimulates lung surfactant production in neonatal rats in vivo. Pediatr Pulmonol 46(9):882–895
Grier DG, Halliday HL (2004) Effects of glucocorticoids on fetal and neonatal lung development. Treat Respir Med 3:295–306
Hohlfeld JM, Hoymann HG, Tschernig T, Fehrenbach A, Krug N, Fehrenbach H (2004) Keratinocyte growth factor transiently alters pulmonary function in rats. J Appl Physiol 96:704–710
Honiden S, Gong MN (2009) Diabetes, insulin, and development of acute lung injury. Crit Care Med 37:2455–2464
Kasper M, Fuller SD, Schuh D, Muller M (1994) Immunohistological detection of the beta subunit of prolyl 4-hydroxylase in rat and mini pig lungs with radiation-induced pulmonary fibrosis. Virchows Arch 425:513–519
Katoh M (2006) FGF signaling network in the gastrointestinal tract (review). Int J Oncol 29:163–168
Kim HS, Manevich Y, Feinstein SI, Pak JH, Ho YS, Fisher AB (2003) Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 285:L363–L369
Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM (2006) The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. Am J Physiol Endocrinol Metab 291:E115–E127
Kim SY, Chun E, Lee KY (2011) Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ 18:1573–1583
Knebel JW, Aufderheide M, Emura M (1994) Comparison of biological effects of different polycyclic aromatic hydrocarbons in lung cells of hamster and rat in vitro. Toxicol Lett 72:65–72
Koslowski R, Barth K, Augstein A, Tschernig T, Bargsten G, Aufderheide M, Kasper M (2004) A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression. Histochem Cell Biol 121:509–519
Lee TS, Liu YJ, Tang GJ, Yien HW, Wu YL, Kou YR (2008) Wood smoke extract promotes both apoptosis and proliferation in rat alveolar epithelial type II cells: the role of oxidative stress and heme oxygenase-1. Crit Care Med 36:2597–2606
Lin S, Ikegami M, Xu Y, Bosserhoff AK, Malkinson AM, Shannon JM (2008) Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. Dev Biol 316:441–455
Mason RJ, Pan T, Edeen KE, Nielsen LD, Zhang F, Longphre M, Eckart MR, Neben S (2003) Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells. J Clin Invest 112:244–255
Matsumura Y, Ban N, Inagaki N (2008) Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease. Am J Physiol Lung Cell Mol Physiol 295:L698–L707
Matsuzaki Y, Besnard V, Clark JC, Xu Y, Wert SE, Ikegami M, Whitsett JA (2008) STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells. Am J Respir Cell Mol Biol 38:551–558
Mulugeta S, Gray JM, Notarfrancesco KL, Gonzales LW, Koval M, Feinstein SI, Ballard PL, Fisher AB, Shuman H (2002) Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 277:22147–22155
Nie Q, Fang M, Xie L, Shi J, Zhang X (2009) cDNA cloning, characterization, and variation analysis of chicken adipose triglyceride lipase (ATGL) gene. Mol Cell Biochem 320:67–74
Pagano A, Barazzone-Argiroffo C (2003) Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci 1010:405–416
Philip AG (2012) Bronchopulmonary dysplasia: then and now. Neonatology 102:1–8
Portnoy J, Curran-Everett D, Mason RJ (2004) Keratinocyte growth factor stimulates alveolar type II cell proliferation through the extracellular signal-regulated kinase and phosphatidylinositol 3-OH kinase pathways. Am J Respir Cell Mol Biol 30:901–907
Post M, Souza P, Liu J, Tseu I, Wang J, Kuliszewski M, Tanswell AK (1996) Keratinocyte growth factor and its receptor are involved in regulating early lung branching. Development 122:3107–3115
Raith M, Schaal K, Koslowski R, Fehrenbach H, Poets CF, Schleicher ED, Bernhard W (2012) Effects of recombinant human keratinocyte growth factor on surfactant, plasma and liver phospholipid homeostasis in hyperoxic neonatal rats. J Appl Physiol 112(8):1317–1328
Ray P, Devaux Y, Stolz DB, Yarlagadda M, Watkins SC, Lu Y, Chen L, Yang XF, Ray A (2003) Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc Natl Acad Sci USA 100:6098–6103
Ridsdale R, Roth-Kleiner M, D’Ovidio F, Unger S, Yi M, Keshavjee S, Tanswell AK, Post M (2005) Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease. Am J Respir Crit Care Med 172:225–232
Rooney SA (2001) Regulation of surfactant secretion. Comp Biochem Physiol A Mol Integr Physiol 129:233–243
Smirnova E, Goldberg EB, Makarova KS, Lin L, Brown WJ, Jackson CL (2006) ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep 7:106–113
Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, Xu Y, von Zychlin K, Olson SJ, Whitsett JA (2007) Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 55:71–83
Ulich TR, Yi ES, Longmuir K, Yin S, Biltz R, Morris CF, Housley RM, Pierce GF (1994) Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 93:1298–1306
Ware LB, Matthay MA (2002) Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 282:L924–L940
White AC, Xu J, Yin Y, Smith C, Schmid G, Ornitz DM (2006) FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development 133:1507–1517
Whitsett JA (2010) Review: the intersection of surfactant homeostasis and innate host defense of the lung: lessons from newborn infants. Innate Immun 16:138–142
Yamano G, Funahashi H, Kawanami O, Zhao LX, Ban N, Uchida Y, Morohoshi T, Ogawa J, Shioda S, Inagaki N (2001) ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 508:221–225
Yano T, Deterding RR, Simonet WS, Shannon JM, Mason RJ (1996) Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol 15:433–442
Zhang F, Nielsen LD, Lucas JJ, Mason RJ (2004) Transforming growth factor-beta antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor. Am J Respir Cell Mol Biol 31:679–686
Zhang X, Zhang Y, Tao B, Teng L, Li Y, Cao R, Gui Q, Ye M, Mou X, Cheng H, Hu H, Zhou R, Wu X, Xie Q, Ning W, Lai M, Shen H, Feng GS, Ke Y (2012) Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis. Faseb J 26(6):2338–2350
Acknowledgments
The authors thank Petra Peche, Verena Müller and Silvia Bramke for excellent technical assistance. R. Koslowski was supported by German Research Council Projects (KO 2219/4-1 and KO 2219/4-2), R. Koslowski and M. Lange were supported by “Roland Ernst Stiftung für Gesundheitswesen”. W. Bernhard was supported by an institutional grant of the medical faculty of the University of Tübingen (F.1275089) and by German Research Council Project BE2223/2.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Koslowski, R., Kasper, M., Schaal, K. et al. Surfactant metabolism and anti-oxidative capacity in hyperoxic neonatal rat lungs: effects of keratinocyte growth factor on gene expression in vivo. Histochem Cell Biol 139, 461–472 (2013). https://doi.org/10.1007/s00418-012-1038-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-012-1038-9